Myriad Genetics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.25

+0.07 (+2.20%)

As of Aug 8, 1:54 AM ET ·

Analyst Consensus

Sell

Analysts

High

Coverage

Buy 2 13%

Hold 8 53%

Sell 5 33%

Price Target

Analyst Price Target +1,175.1% upside

Low Target $29.39

Average Target $41.44

High Target $63.29

Current Price $3.25

Current
$3.25

Target
$41.44

$29.39 $41.44 avg $63.29

Scenario Analysis

Bear Case

$29.39

804.3%

Low target

Base Case

$41.44

+1,175.1%

Avg target

Bull Case

$63.29

+1,847.4%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$8.59

-62.2% from high

52-Week Low

$2.74

+18.6% from low

Target vs 52W High

$41.44

+382.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%